Nanobiotix S.A annual operating margin
2018
2019
2020
2021
2022
2023
2025
Nanobiotix S.A's operating margin was −33.19% for fiscal 2025.
View full Nanobiotix S.A company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −33.19% | +40.77 pp |
| 2023 | 2023-12-31 | −73.96% | +903.89 pp |
| 2022 | 2022-12-31 | −977.85% | +1008.51 pp |
| 2021 | 2021-12-31 | −1,986.36% | −536.20 pp |
| 2020 | 2020-12-31 | −1,450.16% | +390.81 pp |
| 2019 | 2019-12-31 | −1,840.97% | −976.73 pp |
| 2018 | 2019-01-01 | −864.24% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Over the last five reported fiscal years, Nanobiotix S.A's operating margin increased from −1,840.97% to −33.19%, a change of +1807.78 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanobiotix S.A filings at SEC.gov ↗